About the federation

 

The European Idiopathic Pulmonary Fibrosis and Related Disorders Federation (EU-IPFF) brings together European national patient associations committed to defending their vision of equal access to treatment and care for all IPF patients, regardless of geography, socio-economic status or age. Our common view has encouraged us to officially establish the first European IPF and other related disorders federation in July 2016.

 

What is IPF?

 

Idiopathic Pulmonary Fibrosis (IPF) is a progressive, irreversible, chronic disease of the lungs, which currently affects between 80,000 and 111,000 people in Europe. Every year, additional 30,000-35,000 new patients will be diagnosed with IPF.

 

Latest Tweets